Inmune Bio (INMB) Shares Outstanding (Diluted) (2021 - 2026)
Inmune Bio's Shares Outstanding (Diluted) was 26.72 million in Q2 2026, up 14.7% from 23.3 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Inmune Bio came in at 24.76 million, up 24.1% from FY2024.
- Shares Outstanding (Diluted) has now increased for four consecutive years, with a four-year compound annual growth rate of 11.3% (FY2021 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 19.94 million in FY2024 (+10.9%), 17.98 million in FY2023 (+0.3%), 17.93 million in FY2022 (+11.1%) and 16.13 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2021.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 12 straight quarters, with growth averaging 19.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.0% in Q2 2023 to 31.7% in Q3 2025.
- Per Business Quant data, INMB's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 26.59 million (Q1 2026), 24.76 million (Q4 2025) and 26.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Inmune Bio | 53.92 Mn | -38.33 Mn | - | 26.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.72 Mn |
| Mar 31, 2026 | 26.59 Mn |
| Dec 31, 2025 | 24.76 Mn |
| Sep 30, 2025 | 26.59 Mn |
| Jun 30, 2025 | 23.30 Mn |
| Mar 31, 2025 | 22.50 Mn |
| Dec 31, 2024 | 19.94 Mn |
| Sep 30, 2024 | 20.19 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Mar 31, 2024 | 18.03 Mn |
| Dec 31, 2023 | 17.98 Mn |
| Sep 30, 2023 | 18.01 Mn |
| Jun 30, 2023 | 17.95 Mn |
| Mar 31, 2023 | 17.95 Mn |
| Dec 31, 2022 | 17.93 Mn |
| Sep 30, 2022 | 17.95 Mn |
| Jun 30, 2022 | 17.95 Mn |
| Mar 31, 2022 | 17.87 Mn |
| Dec 31, 2021 | 16.13 Mn |
| Sep 30, 2021 | 17.33 Mn |
API Access
Inmune Bio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();